Work

A phase IB study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8594

Authors: David S. Hong, Corina Andresen, Jennifer Mink, Min Ren, James P. O'Brien, Ly Minh Nguyen, Gerald Steven Falchook, Razelle Kurzrock, John J. Nemunaitis

Institutions: The University of Texas MD Anderson Cancer Center, Eisai (United States), Mary Crowley Cancer Research Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600468751

Cites:

Cited by: 3

Related to: 10